X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK Pharma Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Quarterly Results   (GLXO)

Here are the latest quarterly results of GSK Pharma. For more details, see the GSK Pharma financial fact sheet and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

GSK Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m6,2837,0017,3566,9307,0537,9917,0647,837 
Other income Rs m399313265241240181148149 
Turnover Rs m6,6827,3147,6217,1717,2948,1727,2127,986 
Expenses Rs m5,2075,7916,2935,4796,1326,5826,3646,469 
Gross profit Rs m1,1001,2891,0631,4519221,4097001,626 
Depreciation Rs m4953786754666678 
Interest Rs m00000000 
Profit before tax Rs m1,4501,5491,2491,6251,1081,5247821,697 
Tax Rs m493510450565386536252570 
Profit after tax Rs m9571,0397991,0607239895301,127 
Gross profit margin %17.518.414.420.913.117.69.920.7 
Effective tax rate %34.032.936.034.834.835.132.333.6 
Net profit margin %15.214.810.915.310.212.47.514.4 
Diluted EPS Rs 11.3 12.3 9.4 12.5 8.5 11.7 6.3 13.3  
Diluted EPS (TTM) Rs 50.1 47.2 45.8 45.5 42.7 42.1 39.0 39.8  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   STRIDES SHASUN LTD  PIRAMAL ENTERPRISES  IPCA LABS  UNICHEM LAB  PFIZER  

Compare GSK PHARMA With:   STRIDES SHASUN LTD  PIRAMAL ENTERPRISES  IPCA LABS  UNICHEM LAB  PFIZER  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty Ends Above 10,000; Yes Bank Surges 6% on Strong Q1 Result(Closing)

Share markets in India ended the day higher with Nifty50 settling above the 10,000-mark for the first time. At the closing bell, the BSE Sensex closed higher by 154 points.

Views on news

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

More Views on News

Most Popular

Ride the Bull Wave with These Perfect Proxies to India's Growth Story(The 5 Minute Wrapup)

Jul 15, 2017

The secret of spotting multibaggers before they become a hit.

The Real Returns from Real Estate Have Been Very Low(Vivek Kaul's Diary)

Jul 17, 2017

Real estate prices across India have barely gone anywhere over the last four years. Prices have fallen in many cities over the last one-year, new data from the National Housing Bank suggests.

Trade the Markets like Roger Federer Plays Tennis(Daily Profit Hunter)

Jul 19, 2017

Trading is one of the most competitive fields in the world today. To win, you must adopt the mindset of a Grand Slam champion.

Sold Your Immoveable Property? Here Are The Tax Implications...(Outside View)

Jul 19, 2017

When you're selling an immoveable property, it becomes imperative to recognise the intricate tax implications.

Affordable Housing Gaining Traction(Chart Of The Day)

Jul 15, 2017

Affordable housing is gaining traction amid continuing slowdown in the property market.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jul 26, 2017 03:36 PM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

COMPARE GSK PHARMA WITH

MARKET STATS